Zoledronic Acid in MS-patients With Osteoporosis

NCT01166178 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis
Multiple Sclerosis

Interventions

DRUG: Zoledronic Acid
DRUG: Placebo
DIETARY_SUPPLEMENT: Calcium and Vitamin D combination

Sponsor

Novartis